We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lilly, Merck Enter Collaboration Agreement

News   Jan 16, 2015

 
Lilly, Merck Enter Collaboration Agreement
 
 
Advertisement
 

RELATED ARTICLES

Swapping Alpha Cells for Beta Cells To Treat Diabetes

News

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead.

READ MORE

Making Personalized Cancer Therapies Effective for Multiple Patients

News

A new commentary in Science proposes that an emerging method of protein-based immunotherapy that works by targeting commonly occurring mutations in cancer cells, could lead to treatments that are effective for oncology patients.

READ MORE

Asymptomatic COVID-19 Associated With a Balanced T-Cell Response

News

Researchers attempting to determine whether or not an infected individual will develop COVID-19 suggest that clearing the virus without developing symptoms requires T cells to mount an efficient immune response that produces a careful balance of pro- and anti-inflammatory molecules.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE